why choose us

First received: August 22, 2023

Clinical Trial: A Study of the Efficacy and Safety of Brensocatib in Participants With Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP)

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Chronic Rhinosinusitis Without Nasal Polyps

Study Type: INTERVENTIONAL


Official Title: A Phase 2b, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of the Efficacy and Safety of Brensocatib in Participants With Chronic Rhinosinusitis Without Nasal Polyps - The BiRCh Study

Brief Summary: The primary purpose of the study is to evaluate the efficacy of brensocatib at 10 and 40 milligrams (mg) once daily (QD) compared with placebo in improving clinical symptoms of CRSsNP.

Read more